← Back to All Filings

The Procter & Gamble Company Registers Four Series of Notes on the NYSE

Low SignificanceNovember 3, 2026 at 5:37:09 PM EST

PROCTER & GAMBLE Co

$PG8-A12BCIK: 0000080424

Subscribe to track PG

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

šŸ“‹ Form 8-A12B Filing: The Procter & Gamble Company • Exchange: New York Stock Exchange • Securities Registered:

  • 3.750% Notes due 2030
  • 4.100% Notes due 2034
  • 4.250% Notes due 2038
  • 4.625% Notes due 2046 • Significance: Low (Routine debt listing)

Comprehensive Analysis

Overview

On November 3, 2026, The Procter & Gamble Company filed a Form 8-A12B with the U.S. Securities and Exchange Commission to register four new series of senior notes for listing on the New York Stock Exchange (NYSE) under Section 12(b) of the Securities Exchange Act of 1934.

Registered Securities

The classes of securities registered under this filing include:

  • 3.750% Notes due 2030 (ISIN: XS3553990360, CUSIP: 742718 GZ6)
  • 4.100% Notes due 2034
  • 4.250% Notes due 2038
  • 4.625% Notes due 2046

These securities were issued under an Indenture dated September 3, 2009, between Procter & Gamble and Deutsche Bank Trust Company Americas as Trustee, following the Prospectus Supplement dated October 27, 2026 (Registration Statement No. 333-299472).

Market Impact & Significance

This filing represents standard registration paperwork to facilitate exchange trading of previously issued institutional debt securities. It carries low market and trading significance for Procter & Gamble's common equity.

Topics:#PG#ProcterAndGamble#DebtOffering#NYSE#SEC

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.